Temozolomide and its stability—a critical factor

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.

Original languageEnglish
Pages (from-to)1841-1845
Number of pages5
JournalAdvanced Science Letters
Volume23
Issue number3
DOIs
Publication statusPublished - 01-03-2017

Fingerprint

temozolomide
Drugs
drug
Degradation
Pharmaceutical Preparations
Alkylating Agents
Glioblastoma
Batch
degradation
Evaluate

All Science Journal Classification (ASJC) codes

  • Health(social science)
  • Computer Science(all)
  • Education
  • Mathematics(all)
  • Environmental Science(all)
  • Engineering(all)
  • Energy(all)

Cite this

@article{cd45130e3a75426ea2d0ec54f9277f3b,
title = "Temozolomide and its stability—a critical factor",
abstract = "Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.",
author = "Zenab Attari and Rao, {C. Mallikarjuna} and Lalit Kumar and Koteshwara, {K. B.}",
year = "2017",
month = "3",
day = "1",
doi = "10.1166/asl.2017.8486",
language = "English",
volume = "23",
pages = "1841--1845",
journal = "Advanced Science Letters",
issn = "1936-6612",
publisher = "American Scientific Publishers",
number = "3",

}

Temozolomide and its stability—a critical factor. / Attari, Zenab; Rao, C. Mallikarjuna; Kumar, Lalit; Koteshwara, K. B.

In: Advanced Science Letters, Vol. 23, No. 3, 01.03.2017, p. 1841-1845.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Temozolomide and its stability—a critical factor

AU - Attari, Zenab

AU - Rao, C. Mallikarjuna

AU - Kumar, Lalit

AU - Koteshwara, K. B.

PY - 2017/3/1

Y1 - 2017/3/1

N2 - Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.

AB - Temozolomide is an alkylating agent, used in the treatment of glioblastoma multiforme. The characterization of the pure drug and its expired batch was carried out to evaluate the changes occurred due to degradation of the drug. FT-IR spectrocscopy, DSC analysis and drug content estimation were carried out. The observations indicated the changes in the drug peak and content after expiry period.

UR - http://www.scopus.com/inward/record.url?scp=85017678425&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017678425&partnerID=8YFLogxK

U2 - 10.1166/asl.2017.8486

DO - 10.1166/asl.2017.8486

M3 - Article

VL - 23

SP - 1841

EP - 1845

JO - Advanced Science Letters

JF - Advanced Science Letters

SN - 1936-6612

IS - 3

ER -